efter år
efter måned
Weekly View
efter uge
Daily View
I dag

Vi er bekendt med Danske Regioners ”Fællesregionale principper for efteruddannelse og kompetenceudvikling af regionernes sundhedspersonale”.
Hvis du skal have tilladelse fra f.eks. din afdelingsleder til at deltage, beder vi dig venligst selv sikre dette.
Hvis du ønsker adgang til den fulde invitation som indeholder tilmeldings information, beder vi dig kontakte din afdelingsledelse, som har denne.

Manchester Interstitial Lung Diseases

Fra Onsdag, 04 Marts 2020 -  08:45
Til Torsdag, 05 Marts 2020 - 16:00

Tilmelding | ProgramProgramDay 1 : Wednesday 4th March 20208.45 – 9.00 Registration
9.00– 9.10 Welcome and Introduction : Dr Rayid Abdulqawi
Session 1 Chair : Dr Colm Leonard (Manchester)
9.10 – 9.30 Overview of Interstitial Lung Disease (ILD) classification :
Dr Ian Forrest (Newcastle)
9.30 – 10.20 High-Resolution Computer Tomography (HRCT) masterclass –
How to interpret HRCT : Dr Melanie Greaves (Manchester)
10.20 – 10.50 Coffee/Tea Break
Session 2 ILDs of known causes : Chair: Dr Pilar Rivera Ortega (Manchester)
10.50 – 11.30 Connective Tissue Disease related-ILD :
Dr Rachel Hoyles (Oxford)
11.30 – 12.10 Occupational ILD : Dr Jenny Hoyle (Manchester)
12.10 – 12.40 Drug Induced ILD : Dr Nazia Chaudhuri (Manchester)
12.40 – 13.20 Chronic Hypersensitivity Pneumonitis :
Dr Elizabeth Renzoni (London)
13.20 - 14.20 Lunch Break
Session 3 Chair : Ian Forrest (Newcastle)
14.20 – 15.50
Multidisciplinary team (MDT) cases - ILDs of known cause :
Dr Anjali Crawshaw (Birmingham)
Dr Rebecca Duerden (Thoracic Radiologist, Manchester)
Dr Angeles Montero (Pathologist, Manchester).
15.50 – 16.30 ANCA associated vasculitis : Dr Sahena Haque (Manchester)
16.30 – 17.10 Familial Interstitial Lung Diseases :
Dr Maria Molina-Molina (Barcelona)
17.10 - 17.15 Close : Dr Rayid Abdulqawi
Day 2 : ThurSday 5th March 2020Session 4 Chair : Dr Nazia Chaudhuri (Manchester)
9.00 – 9.40 ILD Year in Review and Horizon Scanning : Dr Simon Hart (Hull)
9.40 – 10.20 Lung Transplantation in ILD : Dr Mo Al-Aloul (Manchester)
10.20 – 11.00 Palliative care in ILD : Dr Sabrina Bajwah (London)
11.00 – 11.30 Coffee/Tea Break
Session 5 ILDs of unknown cause.
Chair : Dr George Margaritopoulos (Manchester)
11.30 – 12.10 IPF : Dr Paul Beirne (Leeds)
12.10 – 12.50 Other Idiopathic ILD’s: Idiopathic NSIP and iCOP………or is it…? :
Dr Lisa Spencer (Liverpool)
12.50 - 13.30 Sarcoidosis : Professor Athol Wells (London)
13.30 – 14.30 Lunch Break
Session 6 Rare ILDs. Chair : Dr Rayid Abdulqawi (Riyadh, Saudi Arabia)
14.30 – 15.00 Cystic lung disease : Dr Simon Johnson (Nottingham)
15.00 - 16.00
Multidisciplinary team (MDT) cases : ILDs of unknown cause :
Dr Shaney Barratt (Bristol), Dr Klaus Irion (Thoracic Radiologist,
Manchester) and Dr Angeles Montero (Pathologist, Manchester)
16.00 Close : Dr Nazia Chaudhuri

Speakers Biography
Dr Rayid Abdulqawi is a consultant respiratory physician practising in Riyadh,
Saudi Arabia and an honorary senior lecturer at the University of Manchester. He
completed his core medical and respiratory medicine training in the West Midlands.
Under the supervision of Prof Jacky Smith and Prof Ashley Woodcock, he performed
a PhD project investigating mechanisms of chronic cough. Following the award
of his CCT in 2015, he was appointed as a consultant in respiratory and general
internal medicine in Wolverhampton. Subsequently, he worked as a respiratory
consultant with a special interest in ILD at Wythenshawe Hospital. He practises
now in Saudi Arabia. He is the founder of the Manchester Interstitial Lung Diseases
Meeting, which started in 2017.
Dr Mo Al-Aloul is a Consultant Respiratory and Transplant Physician at Manchester
University NHS Foundation Trust.
Dr Sabrina Bajwah is a Clinical Senior Lecturer at King’s College London and an
Honorary Consultant in Palliative Care. Dr Bajwah has been a member of the NICE
Quality Standards Committee for Idiopathic Pulmonary Fibrosis and has also been a
member of the Emergency Oxygen Guideline Group for the British Thoracic Society
and Idiopathic Pulmonary Fibrosis clinical and research advisory committees for the
British Lung Foundation. She now works clinically within the palliative care team at
King’s Health Partners, London and runs the first interstitial lung disease palliative
care clinic in the UK whilst continuing to drive forward respiratory palliative care
research. She has been awarded a number of National Institute of Health Research
grants to continue her interstitial lung disease research. She is a world leader in ILD
palliative care research.
Dr Shaney Barratt is a Consultant Respiratory Physician at North Bristol NHS
Trust, Bristol and holds an honorary Associate Researcher position at the University
of Bristol. She originally qualified in medicine from Nottingham University and
completed her respiratory training in the South West of England. She completed her
PhD in 2016 under the supervision of Professor Ann Millar, having been awarded a
Wellcome Research Training Fellowship in 2011. She was appointed as a respiratory
consultant in 2016 with a specialist interest in ILD. She is building research
collaborations in her areas of interest in Connective Tissue disease-associated ILD
and Hypersensitivity Pneumonitis.
Dr Paul Beirne has been clinical lead for the Leeds ILD service since 2007. The
Leeds service provides tertiary referral ILD services to a population of
approximately 3.5 million. He has served on the BTS ILD Specialty Advisory group.
He is the Principal Investigator in Leeds on a number of clinical trials in IPF and
other ILDs.
Dr Nazia Chaudhuri is a respiratory physician and the clinical lead for the
interstitial lung disease (ILD) service at the Manchester University NHS Foundation
Trust (MFT). She is an honorary senior lecturer at the University of Manchester.
She is also deputy Clinical Director of the respiratory directorate at MFT. She
performed a PhD and published her work looking at the cellular interactions and
signalling in response to infection and air pollution. She is the principal investigator
on a number of clinical research trials in idiopathic pulmonary fibrosis (IPF) and
is the UK Chief Investigator of a major clinical trial on progressive ILDs. She is
also co-applicant for a British Lung foundation grant for a study in Sarcoidosis. Dr
Chaudhuri has published her experience in prescribing antifibrotics and delivering
MDT care and has presented over 30 abstracts pertaining to IPF, antifibrotics and
the importance of a multi-disciplinary team approach at all major respiratory
conferences. She is a member of the British Thoracic Society (BTS) lung registry
steering group for the BTS sarcoid and IPF registry.
Anjali Crawshaw completed her undergraduate training at the University of
Oxford. She completed higher specialist training in Respiratory and General
Internal Medicine via Melbourne, Leicester and Oxford. She completed subspecialty
training in interstitial lung disease, TB and cystic fibrosis. She has a strong interest
in education and training and completed a research MSc in Medical Education
at UCL in 2010. She was awarded a Wellcome Trust Clinical Training Fellowship
and subsequently a DPhil from the University of Oxford in 2014 for research
examining dysregulation of innate immune pathways in sarcoidosis. Anjali
Crawshaw was appointed as a Consultant Respiratory Physician at University
Hospitals Birmingham NHS Foundation Trust in 2017. She looks after patients with
a broad range of interstitial lung diseases including idiopathic pulmonary fibrosis,
hypersensitivity pneumonitis and connective tissue disease-associated ILD. She
leads a regional multidisciplinary sarcoidosis service.
Dr Rebecca Duerden currently working at Wythenshawe Hospital, Manchester
University Foundation Trust since 2014, as a specialist Thoracic radiologist,
with interests including interstitial lung disease, asthma, emphysema, thoracic
oncology and interventional thoracic radiology. Previously a consultant at Bristol
Royal Infirmary from 2009 to 2014, covering tertiary level thoracic imaging
and intervention, and cardiac imaging, including GUCH MDT radiology lead for
quaternary services to the South West.
Dr Ian Forrest is a Consultant Respiratory Physician at the Royal Victoria Infirmary,
Newcastle upon Tyne. He established the Newcastle Interstitial Lung Disease
service in 2006 and is one of three ILD Consultants in the team. As ILD lead, Ian has
an active interest in clinical research including GORD, ILD pulmonary rehabilitation
and palliative care in ILD. He is the Training Programme Director for Respiratory
Medicine in the Northern Region.
Dr Melanie Greaves performed a one-year fellowship in Thoracic Imaging at
the University of California at Los Angeles followed by one year as an Assistant
Professor of Thoracic Imaging at the same institution. She was a consultant
in Thoracic Imaging at North Staffs for two years until taking up her current
cardiothoracic post at South Manchester in 1998. She is the principal author of
many papers and book chapters on thoracic imaging and regularly is a national
lecturer in the subject. She has a Special interest in interstitial lung diseases and
has been the principle radiologist for the ILD MDT at MFT since 1998.
Dr Sahena Haque is a consultant rheumatologist and Director of Postgraduate
Medical Education at Wythenshawe Hospital, Manchester University Foundation
Trust. She graduated from the University of Liverpool in 1999 and completed a
PhD in atherosclerosis in SLE at the University of Manchester in 2010. She runs an
MSc module in CTD and Vasculitis at the University of Manchester and leads on the
vasculitis service at Wythenshawe Hospital undertaking with combined clinics with 
respiratory and renal colleagues.
Dr Simon Hart graduated from Edinburgh University and trained in respiratory
and general medicine in Edinburgh, Fife, and Borders. He has a PhD in neutrophil
and macrophage biology in the MRC Centre for Inflammation Research, followed by
an MRC Clinician Scientist fellowship. He is the lead clinician for the Hull Interstitial
Lung Disease service since 2008. His research focuses on the biology of pulmonary
fibrosis and sarcoidosis
Dr Jenny Hoyle developed the Occupational Lung Disease service at North
Manchester General Hospital 1994, which is now one of the largest units in the
UK. She is Occupational Lung Disease Lead for The Northern Care Alliance, an
Honorary Lecturer in Occupational and Environmental Lung Disease at Manchester
University and is a member of the Surveillance of Work-related Occupational
Respiratory Disease committee (SWORD) at Manchester University. Dr Hoyle is a
member of the British Thoracic Society SAG, Group of Occupational Respiratory
Disease Specialists UK and European Respiratory Society Occupational Group,
having lectured both nationally and internationally for these groups and has
multiple publications in the field of Occupational Lung Disease including book
chapters. From July 2018 Dr Hoyle has been the Clinical Respiratory Lead for the
Greater Manchester Strategic Network and hospitals (Theme 3).
Dr Rachel Hoyles leads the regional specialist ILD Service at Oxford University
Hospitals NHS Foundation Trust. She has a clinical and academic interest in
connective tissue disease-associated ILD, having completed a clinical and
translational PhD project investigating the role of lung injury in sclerodermaassociated
lung fibrosis. She has published one of few multi-centre RCTs in
scleroderma-associated pulmonary fibrosis and is local PI for multinational
pharmaceutical and physician-led IPF, CTD-ILD and RA-ILD trials. She has active
research interests in CTD-ILD and clinical outcomes in IPF.
Dr Klaus Irion is a Consultant Chest Radiologist and Co-Lead of the Thoracic
Imaging team at Manchester University NHS Foundation Trust and Honorary
Professor of Thoracic Imaging at the University of Manchester. He graduated
in Brazil in 1987, working as a consultant chest radiologist at the Pavilhao
Pereira Filho of Santa Casa de Porto Alegre until 2003, when he moved to the
UK. Has completed his doctorate in respiratory medicine in 2000 and has an
extensive list of publications with co-authorship in more than 150 papers in peerreviewed
medical journals, over 30 collaborations in book chapters and over 250
presentations as a guest speaker in National and International meetings. He is
a member of the editorial board of the Brazilian Journal of Radiology, Revista
Brasileira de Pneumologia, the Indian Journal of Radiology and Imaging and others.
He is also reviewer to several radiological journals, worldwide. His main interests
are imaging in diffuse lung disease, lung cancer and COPD.
Dr Simon Johnson is Professor and Head of Respiratory Medicine at the University
of Nottingham. His research group work on proteolytic mechanisms in lung
remodelling. Dr Johnson is Director of the National Centre for LAM and an ILD
and CTD-ILD physician.
Dr Colm Leonard is Consultant Clinical Adviser to NICE & Consultant Thoracic
Physician/Honorary Senior Lecturer, Manchester University NHS FT. Dr Leonard has
been part-seconded to NICE as a Consultant Clinical Adviser to the topic selection
team for technology appraisals and Medtech innovation briefings. Dr Leonard
spends 50% of his time in clinical work looking after patients with severe lung
disease, and chairs his hospital’s medicines optimisation committee and sits on the
Greater Manchester Medicines Strategy Board, and is an Honorary Clinical Senior
Lecturer at the University of Manchester.
Dr George Margaritopoulos is a Consultant in Respiratory Medicine with a special
interest in ILDs. Currently, he works in the Manchester University NHS FT. He
graduated from the Medical School of the University of Pavia (Italy), he completed
his training in respiratory medicine in the University Hospital of Heraklio (Crete,
Greece) and received his PhD from the Medical School of the University of Crete
(Greece). He was the recipient of two ERS Fellowships, a short-term in 2008 and a
long term in 2010 (Host Institute: ILD Unit, Royal Brompton Hospital, London, UK).
Dr Margaritopoulos’ research interest is focused on ILDs and has published more
than 50 articles in peer-reviewed journals and has received three research grants
from the Greek Thoracic Society. He has been invited as a speaker in national and
international meetings and has acted as co-chair in various sessions in the annual
ERS congress.
Dr Maria Molina-Molina is a Respiratory Consultant and clinical lead in the ILD
unit of Bellvitge University Hospital (Barcelona, Spain) since 2008. Dr. Molina-Molina
is a world expert in familial ILDs and has extensive research and publications within
this field. Dr. Molina-Molina has five publications in international indexed journals
related to familial pulmonary fibrosis and idiopathic pulmonary fibrosis (IPF)
associated with telomere shortening. Dr. Molina-Molina is the Spanish lead in the
European Respiratory Society Pan-European IPF Registry and Biobank (ARIANE-IPF
Dr Angeles Montero-Fernandez qualified in Madrid (1987), specialized in Anatomic
Pathology (1993) and PhD from the Autonomous University in Barcelona (2009).
She was responsible for the implementation of the first accredited Cytology
Department in Spain at a primary care centre in Barcelona (ISO 9001) in 2001. She
has Fellowships in Forensic autopsy in the Royal Infirmary Hospital in Manchester,
UK (2002) and Thoracic pathology in Mayo Clinic, Arizona, USA, with Professor
Thomas V. Colby and Kevin O. Leslie (2009 and 2010). She has worked as Senior
Consultant Histopathologist in Vall d´Hebron University Hospitals (2004-2012),
Royal Brompton and Harefield NHS Trust Foundation, London and Honorary Senior
Lecturer in Imperial College and Currently is working at Manchester University
Hospital as Cardiothoracic Consultant Histopathologist. She has published 35
articles in peer-review journals.
Dr Elisabetta Renzoni was trained in Respiratory Medicine at the University of
Siena, Italy. In 1999, she was awarded a European Respiratory Society research
fellowship to work at the Royal Brompton ILD Unit. In 2006, she was appointed
Consultant Physician at the Royal Brompton Hospital, and Honorary Senior
Lecturer, Imperial College. In 2008, she was awarded a PhD from Imperial College
London. Dr Renzoni is an ILD specialist, and her clinical interests include connective
tissue disease-associated lung involvement, idiopathic interstitial pneumonias,
sarcoidosis, hypersensitivity pneumonitis and pulmonary vasculitis. Her research
interests include translational and clinical research in pulmonary fibrosis. Dr
Renzoni has led a multi-center randomized controlled clinical trial in collaboration
with Aintree University and North Bristol ILD service, to study the effects of
supplemental oxygen on quality of life in fibrotic lung diseases (NCT02286063),
which has now been completed, with the manuscript describing main results
published recently in the Lancet Respiratory Medicine. She leads a prospective
study (NCT02136394) on the role of gastro-oesophageal reflux in pulmonary
fibrosis in scleroderma, funded by the Scleroderma & Raynaud’s UK. Dr Renzoni
is a coinvestigator on a project aiming to develop an integrated staging system
based on clinical and biomolecular markers for systemic sclerosis-associated lung
disease (Arthritis and Research UK research). Dr Renzoni regularly acts as an expert
reviewer for research grant proposals and respiratory/rheumatology journals and
is frequently invited to speak/chair scientific sessions at national and international
meetings. She is a Fellow of the Higher Education Academy. She is an Associate
Editor for Respirology. She currently chairs the European Respiratory Society
CTD-ILD group.
Dr Pilar Rivera-Ortega is a Respiratory Consultant with expertise in interstitial
lung diseases (ILD), who works in the ILD unit of Wythenshawe Hospital since April
2018, for Manchester University NHS Foundation Trust. Dr Rivera-Ortega has spent
three years as a clinical fellow and training as a specialist in ILD with Dr. Maria
Molina-Molina at Bellvitge University Hospital (Barcelona, Spain). Since November
2016, she is the coordinator of the emerging Spanish ILD group (GEEPID-SEPAR). Dr
Rivera-Ortega has previous experience in telomeropathies and developing a rapid
circuit for assessment of ILDs.
Dr Lisa Spencer is a Consultant Respiratory Physician at Aintree Hospital in
Liverpool. She set up and leads the Regional Liverpool Interstitial Lung Disease
Service. Lisa is the current Honorary Secretary for the British Thoracic Society
(BTS), Chairs the BTS ILD Registry Committee and is the member representing ILD
services on the Respiratory Specialised Clinical Reference Group (CRG). The CRG
interfaces with NHS England to oversee and improve national respiratory specialist
services. She was an invited clinical expert on the NICE single technology appraisal
for pirfenidone and the NICE selection topic committee for nintedanib. Lisa has
over 15 years experience in specialised ILD services, ILD clinical trials and research
studies. In the past she was seconded to be Clinical Director of Acute Medicine
in her trust for 18 months to oversee a period of massive transformation but
thankfully returned to respiratory medicine tired, but relatively unscathed! She also
spent 5 years as a Royal College of Physicians Tutor.
Professor Athol Wells trained at Green Lane Hospital in Auckland, New Zealand.
He then came to Royal Brompton Hospital in 1989 for his post-graduate studies.
Professor Wells speaks around the world at major conferences, including the
American Thoracic Society and European Respiratory Society. He sits on the
American Thoracic Society and European Respiratory Society group revising
idiopathic pulmonary fibrosis guidelines.

Radisson Blu Hotel Manchester Airport,
Chicago Avenue, Manchester, M90 3RA
United Kingdom